Novel heterotypic cell cultures for liver toxicology studies
用于肝毒理学研究的新型异型细胞培养物
基本信息
- 批准号:8323544
- 负责人:
- 金额:$ 18.29万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-08-01 至 2014-07-31
- 项目状态:已结题
- 来源:
- 关键词:AdhesivesAdverse effectsAffectAlcohol consumptionAlcoholsAttentionBMP7 geneCaliberCell Culture SystemCell Culture TechniquesCellsCoculture TechniquesCollagenComplexDevelopmentDrug Metabolic DetoxicationExtracellular MatrixGoalsGrowth FactorHepaticHepatocyteHepatocyte Growth FactorHuman bodyIn VitroInjuryLeadLiverLiver DysfunctionLiver FibrosisLocationMediatingMetabolicMono-SPhenotypePlayPositioning AttributePrincipal InvestigatorPrintingProcessProductionRattusRoleSignal TransductionSignaling MoleculeSpottingsTechnologyTestingTimeLineToxicologyTransforming Growth FactorsTranslatingalcohol effectalcohol exposureautocrinecell typehigh throughput screeningimprintimprovedin vivo Modelnovelparacrinepreventprogramsreceptorresearch studyresponsestellate celltherapeutic target
项目摘要
DESCRIPTION (provided by applicant): The goal of our proposal is to investigate paracrine fibrogenic signaling between parenchymal and non parenchymal liver cells during alcohol injury. Whereas the nonparenchymalcompartment (stellate cells) remains the major player in the development of liver, the role of the parenchymal cells (hepatocytes) in this process is drawing increasing attention. Improved understanding of the roles played by parenchymal and nonparenchymalliver cells during alcohol insult will translate into better, more effective and targeted therapeutics. However, the complex signaling exchange between different liver cell types is difficult to delineate with in vivo models or standard in vitro cell culture approaches. In this proposal, we will utilize a novel liver cell culture approach to investigate !he hypothesis that hepatic production of transforming growth factor (TGF)-¿ plays an important role in initiating the fibrogneic program of stellate cells. This hypothesis will be explored using a novel cell culture system where cell adhesive and/or signaling molecules are imprinted into a culture substrate so as to position discrete groups of hepatocytes and stellate cells in defined locations and in close proximity to each other (see Figure 1 (A,B)). As shown in Figure 1 C, this novel cell culture dish will be used to selectively stimulate hepatocytes within the co-cultures with anti-fibrotic growth factors (GFs) (e.g. HGF and BMP7) during alcohol injury in order to investigate how GF signals delivered to hepatocytes impact activation of neighboring stellate cells. The novelty of the proposed platform lies in our ability to define interactions of two liver cell types cultured in the same dish so as to modulate the phenotype of one cell type and to study the response of the other cell type. This approach is particularly well-suited for improving our understanding of the complex heterotypic signaling underlying liver fibrosis. The novel cell culture system described here is envisioned as an enabling technology for liver toxicology studies and for high-throughput screening of liver-protective molecules.
描述(由申请人提供):我们提案的目标是研究酒精损伤过程中实质和非实质肝细胞之间的旁分泌纤维化信号传导,特别是非实质区室(星状细胞)仍然是肝脏发育的主要参与者,在肝脏发育中发挥着重要作用。实质细胞(肝细胞)在此过程中的作用越来越受到人们的关注,人们越来越了解实质和非实质肝细胞在酒精损伤过程中所起的作用。然而,不同肝细胞类型之间复杂的信号交换很难用体内模型或标准体外细胞培养方法来描述。在本提案中,我们将利用一种新的肝细胞培养方法。调查!肝脏产生转化生长因子 (TGF) 的假设-¿在启动星状细胞的纤维生成程序中发挥重要作用,将使用一种新型细胞培养系统来探索该假设,其中细胞粘附分子和/或信号分子被印迹到培养基质中,以便将离散的肝细胞和星状细胞组定位在其中。确定的位置并且彼此靠近(见图 1 (A,B)),如图 1 C 所示,这种新型细胞培养皿将用于选择性刺激共培养物中的肝细胞。酒精损伤期间的抗纤维化生长因子 (GF)(例如 HGF 和 BMP7),以研究 GF 信号如何传递到肝细胞影响邻近星状细胞的激活。所提出的平台的新颖性在于我们能够定义两个肝脏的相互作用。这种方法特别适合提高我们对肝脏复杂异型信号传导的理解。这里描述的新型细胞培养系统被设想为肝脏毒理学研究和肝脏保护分子高通量筛选的支持技术。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alexander Revzin其他文献
Alexander Revzin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Alexander Revzin', 18)}}的其他基金
Mass spectrometry for highly sensitive and sample-sparing analysis of extracellular vesicles in liver diseases
用于肝脏疾病细胞外囊泡高灵敏度和样品节省分析的质谱法
- 批准号:
10736006 - 财政年份:2023
- 资助金额:
$ 18.29万 - 项目类别:
A microfluidic cell culture platform for personalizing pancreatic cancer therapies
用于个性化胰腺癌治疗的微流控细胞培养平台
- 批准号:
10155447 - 财政年份:2020
- 资助金额:
$ 18.29万 - 项目类别:
A microfluidic cell culture platform for personalizing pancreatic cancer therapies
用于个性化胰腺癌治疗的微流控细胞培养平台
- 批准号:
9882916 - 财政年份:2020
- 资助金额:
$ 18.29万 - 项目类别:
Context rich mass spectrometry of molecular localization and cellular interactions
分子定位和细胞相互作用的上下文丰富质谱分析
- 批准号:
9751908 - 财政年份:2017
- 资助金额:
$ 18.29万 - 项目类别:
Microsystems for Shaping Stem Cell Fate Selections
用于塑造干细胞命运选择的微系统
- 批准号:
9412328 - 财政年份:2016
- 资助金额:
$ 18.29万 - 项目类别:
Microsystems for Shaping Stem Cell Fate Selections
用于塑造干细胞命运选择的微系统
- 批准号:
9889953 - 财政年份:2016
- 资助金额:
$ 18.29万 - 项目类别:
Microsystems for Shaping Stem Cell Fate Selections
用于塑造干细胞命运选择的微系统
- 批准号:
9215666 - 财政年份:2016
- 资助金额:
$ 18.29万 - 项目类别:
Novel heterotypic cell cultures for liver toxicology studies
用于肝毒理学研究的新型异型细胞培养物
- 批准号:
8054693 - 财政年份:2011
- 资助金额:
$ 18.29万 - 项目类别:
Designing a Microenvironment Niche for Liver-Specific Differentiation of hESCs
设计 hESC 肝脏特异性分化的微环境
- 批准号:
8247791 - 财政年份:2010
- 资助金额:
$ 18.29万 - 项目类别:
Designing a Microenvironment Niche for Liver-Specific Differentiation of hESCs
设计 hESC 肝脏特异性分化的微环境
- 批准号:
8448619 - 财政年份:2010
- 资助金额:
$ 18.29万 - 项目类别:
相似国自然基金
基于真实世界医疗大数据的中西药联用严重不良反应监测与评价关键方法研究
- 批准号:82274368
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
OR10G7错义突变激活NLRP3炎症小体致伊马替尼严重皮肤不良反应的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
基于隐狄利克雷分配模型的心血管系统药物不良反应主动监测研究
- 批准号:82273739
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
基于真实世界数据的创新药品上市后严重罕见不良反应评价关键方法研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
D.formicigenerans菌通过调控FoxP3-Treg影响PD-1抑制剂所致免疫相关不良反应的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Retinal-adhesive thermoresponsive gel for AAV-mediated gene delivery to the outer retina
用于将 AAV 介导的基因传递至外视网膜的视网膜粘附热敏凝胶
- 批准号:
10709508 - 财政年份:2022
- 资助金额:
$ 18.29万 - 项目类别:
Retinal-adhesive thermoresponsive gel for AAV-mediated gene delivery to the outer retina
用于将 AAV 介导的基因传递至外视网膜的视网膜粘附热敏凝胶
- 批准号:
10453146 - 财政年份:2022
- 资助金额:
$ 18.29万 - 项目类别:
Targeting the Genus Leishmania with Small Molecules
用小分子靶向利什曼原虫属
- 批准号:
10579191 - 财政年份:2021
- 资助金额:
$ 18.29万 - 项目类别:
BIOMATERIALS FOR STEM CELL-DERIVED BETA CELL TRANSPLANTATION
用于干细胞衍生的 β 细胞移植的生物材料
- 批准号:
10306891 - 财政年份:2021
- 资助金额:
$ 18.29万 - 项目类别:
BIOMATERIALS FOR STEM CELL-DERIVED BETA CELL TRANSPLANTATION
用于干细胞衍生的 β 细胞移植的生物材料
- 批准号:
10684716 - 财政年份:2021
- 资助金额:
$ 18.29万 - 项目类别: